Skip to main content Accessibility help
×
Home

New developments in human neurocognition: clinical, genetic, and brain imaging correlates of impulsivity and compulsivity

  • Naomi A Fineberg (a1) (a2) (a3), Samuel R. Chamberlain (a3) (a4), Anna E. Goudriaan (a5) (a6), Dan J. Stein (a7), Louk J. M. J. Vanderschuren (a8) (a9), Claire M. Gillan (a10) (a11), Sameer Shekar (a1), Philip A. P. M. Gorwood (a12) (a13), Valerie Voon (a10) (a14), Sharon Morein-Zamir (a10) (a14), Damiaan Denys (a15) (a16), Barbara J. Sahakian (a3) (a10), F. Gerard Moeller (a17), Trevor W. Robbins (a10) (a11) and Marc N. Potenza (a18)...

Abstract

Impulsivity and compulsivity represent useful conceptualizations that involve dissociable cognitive functions, which are mediated by neuroanatomically and neurochemically distinct components of cortico-subcortical circuitry. The constructs were historically viewed as diametrically opposed, with impulsivity being associated with risk-seeking and compulsivity with harm-avoidance. However, they are increasingly recognized to be linked by shared neuropsychological mechanisms involving dysfunctional inhibition of thoughts and behaviors. In this article, we selectively review new developments in the investigation of the neurocognition of impulsivity and compulsivity in humans, in order to advance our understanding of the pathophysiology of impulsive, compulsive, and addictive disorders and indicate new directions for research.

Copyright

Corresponding author

*Address for correspondence: Prof. Naomi A. Fineberg, Hertfordshire Partnership NHS University Foundation Trust, Queen Elizabeth II Hospital, Howlands, Welwyn Garden City, Hertfordshire, AL7 4HQ, UK. (Email: naomi.fneberg@hpft.nhs.uk)

Footnotes

Hide All

This research was funded in part by NIH grants from NIDA (R01 DA 019039, R01 DA018647, P20 DA027844) and NIAAA (RL1 AA017539), the Connecticut State Department of Mental Health and Addictions Services, the Connecticut Mental Health Center, an unrestricted research gift from the Mohegan Sun casino, and the Yale Gambling Center of Research Excellence Award grant from the National Center for Responsible Gaming. The funding agencies did not provide input or comment on the content of the manuscript, and the content of the manuscript reflects the contributions and thoughts of the authors and not necessarily reflect the views of the funding agencies. A.G. was supported by an Addiction Program grant from the Netherlands Organization for Scientific Research (NWO-ZonMW grant 31160003). This research was also supported by the European College of Neuropsychopharmacology (ECNP) Networks Initiative and the International College of Obsessive Compulsive Spectrum Disorders.

We would like to thank Mr. Sameer Shekar for editing and formatting the manuscript and coordinating its submission.

Footnotes

References

Hide All
1. Chamberlain, SR, Sahakian, BJ. The neuropsychiatry of impulsivity. Curr Opin Psychiatry. 2007; 20(3): 255261.
2. Potenza, MN. To do or not to do? The complexities of addiction, motivation, self-control, and impulsivity. Am J Psychiatry. 2007; 164(1): 46.
3. Chamberlain, SR, Fineberg, NA, Blackwell, AD, Robbins, TW, Sahakian, BJ. Motor inhibition and cognitive flexibility in obsessive-compulsive disorder and trichotillomania. Am J Psychiatry. 2006; 163(7): 12821284.
4. Hollander, E, Cohen, LJ. Impulsivity and Compulsivity. Washington, DC: American Psychiatric Press; 1996.
5. World Health Organization. International Classification of Diseases, 10th ed. (ICD-10). Geneva: World Health Organization; 1992.
6. Stein, DJ, Hollander, E. Obsessive-compulsive spectrum disorders. J Clin Psychiatry. 1995; 56(6): 265266.
7. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th ed. Washington, DC: American Psychiatric Association; 2013.
8. Everitt, BJ, Robbins, TW. Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci. 2005; 8(11): 14811489.
9. Robbins, TW, Gillan, CM, Smith, DG, de Wit, S, Ersche, KD. Neurocognitive endophenotypes of impulsivity and compulsivity: towards dimensional psychiatry. Trends Cogn Sci. 2012; 16(1): 8191.
10. Brewer, JA, Potenza, MN. The neurobiology and genetics of impulse control disorders: relationships to drug addictions. Biochem Pharmacol. 2008; 75(1): 6375.
11. Hollander, E, Kim, S, Khanna, S, Pallanti, S. Obsessive-compulsive disorder and obsessive-compulsive spectrum disorders: diagnostic and dimensional issues. CNS Spectr. 2007; 12(2 Suppl 3): 513.
12. Bienvenu, OJ, Samuels, JF, Wuyek, LA, etal. Is obsessive-compulsive disorder an anxiety disorder, and what, if any, are spectrum conditions? A family study perspective. Psychol Med. 2012; 42(1): 113.
13. Chamberlain, SR, Blackwell, AD, Fineberg, NA, Robbins, TW, Sahakian, BJ. The neuropsychology of obsessive compulsive disorder: the importance of failures in cognitive and behavioural inhibition as candidate endophenotypic markers. Neurosci Biobehav Rev. 2005; 29(3): 399419.
14. Kolevzon, A, Mathewson, KA, Hollander, E. Selective serotonin reuptake inhibitors in autism: a review of efficacy and tolerability. J Clin Psychiatry. 2006; 67(3): 407414.
15. Van Ameringen, M, Mancini, C, Patterson, B, Bennett, M, Oakman, J. A randomized placebo controlled trial of olanzapine in trichotillomania. Eur Neuropsychopharmacol. 2006; 16(suppl 4): S452.
16. Grant, JE, Odlaug, BL, Kim, SW. N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: a double-blind, placebo-controlled study. Arch Gen Psychiatry. 2009; 66(7): 756763.
17. Weisman, H, Qureshi, IA, Leckman, JF, Scahill, L, Bloch, MH. Systematic review: Pharmacological treatment of tic disorders—efficacy of antipsychotic and alpha-2 adrenergic agonist agents. Neurosci Biobehav Rev. 2012; 37(6): 11621171.
18. Brewer, JA, Worhunsky, PD, Carroll, KM, Rounsaville, BJ, Potenza, MN. Pretreatment brain activation during Stroop task is associated with outcomes in cocaine-dependent patients. Biol Psychiatry. 2008; 64(11): 9981004.
19. Gottesman, II, Gould, TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry. 2003; 160(4): 636645.
20. Chamberlain, SR, Menzies, L. Endophenotypes of obsessive-compulsive disorder: rationale, evidence and future potential. Expert Rev Neurother. 2009; 9(8): 11331146.
21. Kashyap, H, Fontenelle, LF, Miguel, EC, etal. Impulsive compulsivity’ in obsessive-compulsive disorder: a phenotypic marker of patients with poor clinical outcome. J Psychiatr Res. 2012; 46(9): 11461152.
22. National Institute of Mental Health. Research domain criteria (RDoC). National Institute of Mental Health Web site. http://www.nimh.nih.gov/research-funding/rdoc/index.shtml. Accessed January 1, 2014.
23. Robbins, TW. Shifting and stopping: fronto-striatal substrates, neurochemical modulation and clinical implications. Philos Trans R Soc Lond B Biol Sci. 2007; 362(1481): 917932.
24. van den Heuvel, OA, Veltman, DJ, Groenewegen, HJ, etal. Frontal-striatal dysfunction during planning in obsessive-compulsive disorder. Arch Gen Psychiatry. 2005; 62(3): 301309.
25. Page, LA, Rubia, K, Deeley, Q, etal. A functional magnetic resonance imaging study of inhibitory control in obsessive-compulsive disorder. Psychiatry Res. 2009; 174(3): 202209.
26. Gu, BM, Park, JY, Kang, DH, etal. Neural correlates of cognitive inflexibility during task-switching in obsessive-compulsive disorder. Brain. 2008; 131(Pt 1): 155164.
27. Chamberlain, SR, Menzies, L, Hampshire, A, etal. Orbitofrontal dysfunction in patients with obsessive-compulsive disorder and their unaffected relatives. Science. 2008; 321(5887): 421422.
28. Hollander, E, Wong, CM. Obsessive-compulsive spectrum disorders. J Clin Psychiatry. 1995; 56(4): 36; discussion 53–55.
29. Goldstein, RZ, Volkow, ND. Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications. Nat Rev Neurosci. 2011; 12(11): 652669.
30. Luigjes, J, Mantione, M, van den Brink, W, etal. Deep brain stimulation increases impulsivity in two patients with obsessive-compulsive disorder. Int Clin Psychopharmacol. 2011; 26(6): 338340.
31. Fineberg, NA, Robbins, TW, Bullmore, E, etal. Probing compulsive and impulsive behaviors, from animal models to endophenotypes: a narrative review. Neuropsychopharmacology. 2010; 35(3): 591604.
32. Potenza, MN, de Wit, H. Control yourself: alcohol and impulsivity. Alcohol Clin Exp Res. 2010; 34(8): 13031305.
33. Aron, AR, Poldrack, RA. The cognitive neuroscience of response inhibition: relevance for genetic research in attention-deficit/hyperactivity disorder. Biol Psychiatry. 2005; 57(11): 12851292.
34. Logan, GD, Cowan, WB, Davis, KA. On the ability to inhibit simple and choice reaction time responses: a model and a method. J Exp Psychol Hum Percept Perform. 1984; 10(2): 276291.
35. Rubia, K, Smith, AB, Brammer, MJ, Taylor, E. Right inferior prefrontal cortex mediates response inhibition while mesial prefrontal cortex is responsible for error detection. Neuroimage. 2003; 20(1): 351358.
36. Chamberlain, SR, Muller, U, Blackwell, AD, etal. Neurochemical modulation of response inhibition and probabilistic learning in humans. Science. 2006; 311(5762): 861863.
37. Chamberlain, SR, Del Campo, N, Dowson, J, etal. Atomoxetine improved response inhibition in adults with attention deficit/hyperactivity disorder. Biol Psychiatry. 2007; 62(9): 977984.
38. Chamberlain, SR, Robbins, TW. Noradrenergic modulation of cognition: therapeutic implications. J Psychopharmacol. 2013; 27(8): 694718.
39. Clarke, HF, Walker, SC, Crofts, HS, etal. Prefrontal serotonin depletion affects reversal learning but not attentional set shifting. J Neurosci. 2005; 25(2): 532538.
40. Boonstra, AM, Oosterlaan, J, Sergeant, JA, Buitelaar, JK. Executive functioning in adult ADHD: a meta-analytic review. Psychol Med. 2005; 35(8): 10971108.
41. Chamberlain, SR, Robbins, TW, Winder-Rhodes, S, etal. Translational approaches to frontostriatal dysfunction in attention-deficit/hyperactivity disorder using a computerized neuropsychological battery. Biol Psychiatry. 2010; 69(12): 11921203.
42. Aron, AR, Dowson, JH, Sahakian, BJ, Robbins, TW. Methylphenidate improves response inhibition in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry. 2003; 54(12): 14651468.
43. Boonstra, AM, Kooij, JJ, Oosterlaan, J, Sergeant, JA, Buitelaar, JK. Does methylphenidate improve inhibition and other cognitive abilities in adults with childhood-onset ADHD? J Clin Exp Neuropsychol. 2005; 27(3): 278298.
44. Chamberlain, SR, Hampshire, A, Muller, U, etal. Atomoxetine modulates right inferior frontal activation during inhibitory control: a pharmacological functional magnetic resonance imaging study. Biol Psychiatry. 2009; 65(7): 550555.
45. Graf, H, Abler, B, Freudenmann, R, etal. Neural correlates of error monitoring modulated by atomoxetine in healthy volunteers. Biol Psychiatry. 2011; 69(9): 890897.
46. Cubillo, A, Smith, AB, Barrett, N, etal. Shared and drug-specific effects of atomoxetine and methylphenidate on inhibitory brain dysfunction in medication-naive ADHD boys. Cereb Cortex. 2014; 24(1): 174185.
47. Chamberlain, SR, Blackwell, AD, Fineberg, NA, Robbins, TW, Sahakian, BJ. The neuropsychology of obsessive compulsive disorder: the importance of failures in cognitive and behavioural inhibition as candidate endophenotypic markers. Neurosci Biobehav Rev. 2005; 29(3): 399419.
48. Jefferies, K, Laws, K, Fineberg, NA. Cognitive and perceptual processing in body dysmorphic disorder. Eur Neuropsychopharmacol. 2010; 20(3): s309.
49. Chamberlain, SR, Fineberg, NA, Menzies, LA, etal. Impaired cognitive flexibility and motor inhibition in unaffected first-degree relatives of patients with obsessive-compulsive disorder. Am J Psychiatry. 2007; 164(2): 335338.
50. Menzies, L, Achard, S, Chamberlain, SR, etal. Neurocognitive endophenotypes of obsessive-compulsive disorder. Brain. 2007; 130(12): 32233236.
51. de Wit, SJ, de Vries, FE, van der Werf, YD, etal. Presupplementary motor area hyperactivity during response inhibition: a candidate endophenotype of obsessive-compulsive disorder. Am J Psychiatry. 2012; 169(10): 11001108.
52. Odlaug, BL, Chamberlain, SR, Grant, JE. Motor inhibition and cognitive flexibility in pathologic skin picking. Prog Neuropsychopharmacol Biol Psychiatry. 2010; 34(1): 208211.
53. Verbruggen, F, Adams, RC, Van't Wout, F, Stevens, T, McLaren, IP, Chambers, CD. Are the effects of response inhibition on gambling long-lasting? PLOS-one. 2013; 8(7): e70155. doi 10.1371/journal.pone.0070155 (in press).
54. Lawrence, AJ, Luty, J, Bogdan, NA, Sahakian, BJ, Clark, L. Impulsivity and response inhibition in alcohol dependence and problem gambling. Psychopharmacology (Berl). 2009; 207(1): 163172.
55. Grant, JE, Odlaug, BL, Chamberlain, SR. A cognitive comparison of pathological skin picking and trichotillomania. J Psychiatr Res. 2011; 45(12): 16341638.
56. Odlaug, BL, Chamberlain, SR, Harvanko, AM, Grant, JE. Age at onset in trichotillomania: clinical variables and neurocognitive performance. Prim Care Companion CNS Disord. 2012; 14(4).
57. 9th Annual Scientific Meeting of the International Society for Research on Impulsivity. May 15, 2013; San Francisco, CA. http://www.impulsivity.org/pdf/Meeting%20Program%202013.pdf.
58. Cavedini, P, Riboldi, G, D'Annucci, A, etal. Decision-making heterogeneity in obsessive-compulsive disorder: ventromedial prefrontal cortex function predicts different treatment outcomes. Neuropsychologia. 2002; 40: 205211.
59. Nielen, MM, Veltman, DJ, de Jong, R, Mulder, G, den Boer, JA. Decision making performance in obsessive compulsive disorder. J Affect Disord. 2002; 69(1–3): 257260.
60. Fellows, LK, Farah, MJ. Different underlying impairments in decision-making following ventromedial and dorsolateral frontal lobe damage in humans. Cereb Cortex. 2005; 15(1): 5863.
61. Lawrence, AJ, Luty, J, Bogdan, NA, Sahakian, BJ, Clark, L. Problem gamblers share deficits in impulsive decision-making with alcohol-dependent individuals. Addiction. 2009; 104(6): 10061015.
62. Rogers, RD, Everitt, BJ, Baldacchino, A, etal. Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan-depleted normal volunteers: evidence for monoaminergic mechanisms. Neuropsychopharmacology. 1999; 20(4): 322339.
63. Zeeb, FD, Robbins, TW, Winstanley, CA. Serotonergic and dopaminergic modulation of gambling behavior as assessed using a novel rat gambling task. Neuropsychopharmacology. 2009; 34(10): 23292343.
64. Baarendse, PJJ, Winstanley, CA, Vanderschuren, LJMJ. Simultaneous blockade of dopamine and noradrenaline reuptake promotes disadvantageous decision making in a rat gambling task. Psychopharmacology (Berl). 2013; 225(3): 719731.
65. Sachdev, PS, Malhi, GS. Obsessive-compulsive behaviour: a disorder of decision-making. Aust N Z J Psychiatry. 2005; 39(9): 757763.
66. Chamberlain, SR, Fineberg, NA, Blackwell, AD, etal. A neuropsychological comparison of obsessive-compulsive disorder and trichotillomania. Neuropsychologia. 2007; 45(4): 654662.
67. DeVito, EE, Blackwell, AD, Kent, L, etal. The effects of methylphenidate on decision making in attention-deficit/hyperactivity disorder. Biol Psychiatry. 2008; 64(7): 636639.
68. Odlaug, BL, Chamberlain, SR, Kim, SW, Schreiber, LR, Grant, JE. A neurocognitive comparison of cognitive flexibility and response inhibition in gamblers with varying degrees of clinical severity. Psychol Med. 2011; 41(10): 21112119.
69. Passetti, F, Clark, L, Davis, P, etal. Risky decision-making predicts short-term outcome of community but not residential treatment for opiate addiction: implications for case management. Drug Alcohol Depend. 2011; 118(1): 1218.
70. Evenden, JL, Ryan, CN. The pharmacology of impulsive behaviour in rats VI: the effects of ethanol and selective serotonergic drugs on response choice with varying delays of reinforcement. Psychopharmacology (Berl). 1999; 146(4): 413421.
71. Cardinal, RN. Neural systems implicated in delayed and probabilistic reinforcement. Neural Netw. 2006; 19(8): 12771301.
72. Winstanley, CA, Theobald, DE, Dalley, JW, Cardinal, RN, Robbins, TW. Double dissociation between serotonergic and dopaminergic modulation of medial prefrontal and orbitofrontal cortex during a test of impulsive choice. Cereb Cortex. 2006; 16(1): 106114.
73. Dalley, JW, Roiser, JP. Dopamine, serotonin and impulsivity. Neuroscience. 2012; 215: 4258.
74. Pattij, T, Vanderschuren, LJMJ. The neuropharmacology of impulsive behavior. Trends Pharmacol Sci. 2008; 29(4): 192199.
75. van Gaalen, MM, van Koten, R, Schoffelmeer, AN, Vanderschuren, LJ. Critical involvement of dopaminergic neurotransmission in impulsive decision making. Biol Psychiatry. 2006; 60(1): 6673.
76. Baarendse, PJJ, Vanderschuren, LJMJ. Dissociable effects of monoamine reuptake inhibitors on distinct forms of impulsive behavior in rats. Psychopharmacology (Berl). 2012; 219(2): 313326.
77. Floresco, SB, Tse, MT, Ghods-Sharifi, S. Dopaminergic and glutamatergic regulation of effort- and delay-based decision making. Neuropsychopharmacology. 2008; 33(8): 19661979.
78. Wischhof, L, Hollensteiner, KJ, Koch, M. Impulsive behaviour in rats induced by intracortical DOI infusions is antagonized by co-administration of an mGlu2/3 receptor agonist. Behav Pharmacol. 2011; 22(8): 805813.
79. Cottone, P, Iemolo, A, Narayan, AR, etal. The uncompetitive NMDA receptor antagonists ketamine and memantine preferentially increase the choice for a small, immediate reward in low-impulsive rats. Psychopharmacology (Berl). 2013; 226(1): 127138.
80. Wiskerke, J, Stoop, N, Schetters, D, Schoffelmeer, ANM, Pattij, T. Cannabinoid CB1 receptor activation mediates the opposing effects of amphetamine on impulsive action and impulsive choice. PLoS One. 2011; 6(10): e25856.
81. Navarrete, F, Pérez-Ortiz, JM, Manzanares, J. Cannabinoid CB2 receptor-mediated regulation of impulsive-like behaviour in DBA/2 mice. Br J Pharmacol. 2012; 165(1): 260273.
82. Winstanley, CA. The utility of rat models of impulsivity in developing pharmacotherapies for impulse control disorders. Br J Pharmacol. 2011; 164: 13011321.
83. Peters, J, Buchel, C. The neural mechanisms of inter-temporal decision-making: understanding variability. Trends Cogn Sci. 2011; 15(5): 227239.
84. Peper, JS, Mandl, RC, Braams, BR, etal. Delay discounting and frontostriatal fiber tracts: a combined DTI and MTR study on impulsive choices in healthy young adults. Cereb Cortex. 2012; 23(7): 16951702.
85. Rapport, MD, Tucker, SB, DuPaul, GJ, Merlo, M, Stoner, G. Hyperactivity and frustration: the influence of control over and size of rewards in delaying gratification. J Abnorm Child Psychol. 1986; 14(2): 191204.
86. Sonuga-Barke, EJ, Taylor, E, Heptinstall, E. Hyperactivity and delay aversion—II. The effect of self versus externally imposed stimulus presentation periods on memory. J Child Psychol Psychiatry. 1992; 33(2): 399409.
87. Sonuga-Barke, EJ, Taylor, E, Sembi, S, Smith, J. Hyperactivity and delay aversion—I. The effect of delay on choice. J Child Psychol Psychiatry. 1992; 33(2): 387398.
88. Tripp, G, Alsop, B. Sensitivity to reward delay in children with attention deficit hyperactivity disorder (ADHD). J Child Psychol Psychiatry. 2001; 42(5): 691698.
89. Shields, K, Hawk, LW Jr, Reynolds, B, etal. Effects of methylphenidate on discounting of delayed rewards in attention deficit/hyperactivity disorder. Exp Clin Psychopharmacol. 2009; 17(5): 291301.
90. Dalley, JW, Everitt, BJ, Robbins, TW. Impulsivity, compulsivity, and top-down cognitive control. Neuron. 2011; 69(4): 680694.
91. De Wit, H. Impulsivity as a determinant and consequence of drug use: a review of underlying processes. Addict Biol. 2009; 14(1): 2231.
92. Perry, JL, Carroll, ME. The role of impulsive behavior in drug abuse. Psychopharmacology (Berl). 2008; 200(1): 126.
93. Bickel, WK, Odum, AL, Madden, GJ. Impulsivity and cigarette smoking: delay discounting in current, never, and ex-smokers. Psychopharmacology (Berl). 1999; 146(4): 447454.
94. Madden, GJ, Petry, NM, Badger, GJ, Bickel, WK. Impulsive and self-control choices in opioid-dependent patients and non-drug-using control participants: drug and monetary rewards. Exp Clin Psychopharmacol. 1997; 5(3): 256262.
95. Petry, NM. Delay discounting of money and alcohol in actively using alcoholics, currently abstinent alcoholics, and controls. Psychopharmacology (Berl). 2001; 154(3): 243250.
96. Petry, NM. Discounting of money, health, and freedom in substance abusers and controls. Drug Alcohol Depend. 2003; 71(2): 133141.
97. Kagan, J. Reflection—impulsivity: the generality and dynamics of conceptual tempo. J Abnorm Psychol. 1966; 71(1): 1724.
98. Clark, L, Robbins, TW, Ersche, KD, Sahakian, BJ. Reflection impulsivity in current and former substance users. Biol Psychiatry. 2006; 60(5): 515522.
99. Evenden, J. The pharmacology of impulsive behaviour in rats V: the effects of drugs on responding under a discrimination task using unreliable visual stimuli. Psychopharmacology (Berl). 1999; 143(2): 111122.
100. Crockett, MJ, Clark, L, Smillie, LD, Robbins, TW. The effects of acute tryptophan depletion on costly information sampling: impulsivity or aversive processing? Psychopharmacology (Berl). 2012; 219(2): 587597.
101. Clark, L, Roiser, JP, Robbins, TW, Sahakian, BJ. Disrupted ‘reflection’ impulsivity in cannabis users but not current or former ecstasy users. J Psychopharmacol. 2009; 23(1): 1422.
102. DeVito, EE, Blackwell, AD, Clark, L, etal. Methylphenidate improves response inhibition but not reflection-impulsivity in children with attention deficit hyperactivity disorder (ADHD). Psychopharmacology (Berl). 2009; 202(1–3): 531539.
103. Snorrason, I, Smari, J, Olafsson, RP. Motor inhibition, reflection impulsivity, and trait impulsivity in pathological skin picking. Behav Ther. 2011; 42(3): 521532.
104. Fineberg, NA, Potenza, MN, Chamberlain, SR, etal. Probing compulsive and impulsive behaviors, from animal models to endophenotypes: a narrative review. Neuropsychopharmacology. 2010; 35(3): 591604.
105. Clarke, HF, Walker, SC, Crofts, HS, etal. Prefrontal serotonin depletion affects reversal learning but not attentional set shifting. J Neurosci. 2005; 25(2): 532538.
106. Pickens, CL, Saddoris, MP, Setlow, B, etal. Different roles for orbitofrontal cortex and basolateral amygdala in a reinforcer devaluation task. J Neurosci. 2003; 23(25): 1107811084.
107. Pickens, CL, Saddoris, MP, Gallagher, M, Holland, PC. Orbitofrontal lesions impair use of cue-outcome associations in a devaluation task. Behav Neurosci. 2005; 119(1): 317322.
108. Ghahremani, DG, Monterosso, J, Jentsch, JD, Bilder, RM, Poldrack, RA. Neural components underlying behavioral flexibility in human reversal learning. Cereb Cortex. 2010; 20(8): 18431852.
109. Schlund, MW, Ortu, D. Experience-dependent changes in human brain activation during contingency learning. Neuroscience. 2010; 165(1): 151158.
110. Wrase, J, Kahnt, T, Schlagenhauf, F, etal. Different neural systems adjust motor behavior in response to reward and punishment. Neuroimage. 2007; 36: 12531262.
111. Boulougouris, V, Dalley, JW, Robbins, TW. Effects of orbitofrontal, infralimbic and prelimbic cortical lesions on serial spatial reversal learning in the rat. Behav Brain Res. 2007; 179(2): 219228.
112. Hornak, J, O'Doherty, J, Bramham, J, etal. Reward-related reversal learning after surgical excisions in orbito-frontal or dorsolateral prefrontal cortex in humans. J Cogn Neurosci. 2004; 16(3): 463478.
113. Remijnse, PL, Nielen, MM, van Balkom, AJ, etal. Reduced orbitofrontal-striatal activity on a reversal learning task in obsessive-compulsive disorder. Arch Gen Psychiatry. 2006; 63: 12251236.
114. Figee, M, Wielaard, I, Mazaheri, A, Denys, D. Neurosurgical targets for compulsivity: what can we learn from acquired brain lesions? Neurosci Biobehav Rev. 2013; 37(3): 328339.
115. Monsell, S. Task switching. Trends Cogn Sci. 2003; 7(3): 134140.
116. Ravizza, SM, Carter, CS. Shifting set about task switching: behavioral and neural evidence for distinct forms of cognitive flexibility. Neuropsychologia. 2008; 46(12): 29242935.
117. Lawrence, AD, Sahakian, B, Robbins, TW. Cognitive functions and corticostriatal circuits: insights from Huntington's disease. Trends Cogn Sci. 1998; 2(10): 379388.
118. Watkins, LH, Sahakian, BJ, Robertson, MM, etal. Executive function in Tourette's syndrome and obsessive-compulsive disorder. Psychol Med. 2005; 35(4): 571582.
119. Fineberg, NA, Sharma, P, Sivakumaran, T, Sahakian, B, Chamberlain, SR. Does obsessive compulsive personality disorder belong within the obsessive-compulsive spectrum? CNS Spectr. 2007; 12(6): 467482.
120. Patel, DD, Laws, KR, Padhi, A, etal. The neuropsychology of the schizo-obsessive subtype of schizophrenia: a new analysis. Psychol Med. 2010; 40(6): 921933.
121. Browning, M, Holmes, EA, Harmer, CJ. The modification of attentional bias to emotional information: a review of the techniques, mechanisms, and relevance to emotional disorders. Cogn Affect Behav Neurosci. 2010; 10(1): 820.
122. Field, M, Cox, WM. Attentional bias in addictive behaviors: a review of its development, causes, and consequences. Drug Alcohol Depend. 2008; 97(1–2): 120.
123. Morein-Zamir, S, Fineberg, NA, Robbins, TW, Sahakian, BJ. Inhibition of thoughts and actions in obsessive-compulsive disorder: extending the endophenotype? Psychol Med. 2010; 40(2): 263272.
124. Moritz, S, Fischer, B, Hottenrott, B, etal. Words may not be enough! No increased emotional Stroop effect in obsessive–compulsive disorder. Behav Res Ther. 2008; 46: 11011104.
125. Moritz, S, Jacobsen, D, Kloss, M, etal. Examination of emotional Stroop interference in obsessive-compulsive disorder. Behav Res Ther. 2004; 42: 671682.
126. Harkness, EL, Harris, LM, Jones, MK, Vaccaro, L. No evidence of attentional bias in obsessive compulsive checking on the dot probe paradigm. Behav Res Ther. 2009; 47: 437443.
127. Kyrios, M, Iob, MA. Automatic and strategic processing in obsessive-compulsive disorder: attentional bias, cognitive avoidance or more complex phenomena? J Anxiety Disord. 1998; 12: 271292.
128. Sizino da Victoria, M, Nascimento, AL, Fontenelle, LF. Symptom-specific attentional bias to threatening stimuli in obsessive-compulsive disorder. Comprehensive Psychiatry. 2012; 53(6): 783788.
129. Clerkin, EM, Teachman, BA. Perceptual and cognitive biases in individuals with body dysmorphic disorder symptoms. Cognition and Emotion. 2008; 22(7): 13271339.
130. Young, A, Perrett, D, Calder, A, Sprengelmeyer, R, Ekman, P. Facial Expressions of Emotion—Stimuli and Tests (FEEST). Version 2.1. London: Adult Mental Health, InnouAct; 2002.
131. Jefferies, K, Laws, K, Fineberg, NA. Superior face recognition in body dysmorphic disorder. Journal of Obsessive-Compulsive and Related Disorders. 2012; 1(3): 175179.
132. Simon, D, Kaufmann, C, Musch, K, Kischkel, E, Kathmann, N. Fronto-striato-limbic hyperactivation in obsessive-compulsive disorder during individually tailored symptom provocation. Psychophysiology. 2010; 47: 728738.
133. van den Heuvel, OA, Veltman, DJ, Groenewegen, HJ, etal. Disorder-specific neuroanatomical correlates of attentional bias in obsessive-compulsive disorder, panic disorder, and hypochondriasis. Arch Gen Psychiatry. 2005; 62: 922933.
134. de Wit, S, Dickinson, A. Associative theories of goal-directed behaviour: a case for animal-human translational models. Psychol Res. 2009; 73: 463476.
135. Dickinson, A, Balleine, B. Actions and responses: the dual psychology of behaviour. In: Spatial Representation: Problems in Philosophy and Psychology. New York, Oxford University Press, 1993: 277293.
136. Adams, C. Variations in the sensitivity of instrumental responding to reinforcer devaluation. Q J Exp Psychol (Colchester). 1982; 34B: 7798.
137. Adams, C, Dickinson, A. Instrumental responding following reinforcer devaluation. Q J Exp Psychol (Colchester). 1981; 33: 109121.
138. Thorndike, A. Animal Intelligence: Experimental Studies. Mcmillan, New York, USA, 1911.
139. Graybiel, AM, Rauch, SL. Toward a neurobiology of obsessive-compulsive disorder. Neuron. 2000; 28: 343347.
140. Gillan, CM, Papmeyer, M, Morein-Zamir, S, etal. Disruption in the balance between goal-directed behavior and habit learning in obsessive-compulsive disorder. Am J Psychiatry. 2011; 168: 718726.
141. Gillan, CM, Morein-Zamir, S, Kaser, M, etal. Counterfactual Processing of Economic Action-Outcome Alternatives in Obsessive-Compulsive Disorder: Further Evidence of Impaired Goal-Directed Behavior. Biol Psychiatry. In press. DOI: 10.1016/j.biopsych.2013.01.018.
142. Gillan, CM, Morein-Zamir, S, Urcelay, GP, etal. Enhanced Avoidance Habits in Obsessive-Compulsive Disorder. Biol Psychiatry. In press. DOI: 10.1016/j.biopsych.2013.02.002.
143. Balleine, BW, O'Doherty, JP. Human and rodent homologies in action control: corticostriatal determinants of goal-directed and habitual action. Neuropsychopharmacology. 2010; 35: 4869.
144. de Wit, S, Watson, P, Harsay, HA, etal. Corticostriatal connectivity underlies individual differences in the balance between habitual and goal-directed action control. J Neurosci. 2012; 32(35): 1206612075.
145. de Wit, S, Standing, HR, Devito, EE, etal. Reliance on habits at the expense of goal-directed control following dopamine precursor depletion. Psychopharmacology (Berl). 2012; 219(2): 621631.
146. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: American Psychiatric Association, Fourth Edition; 2000.
147. Dalley, JW, Everitt, BJ, Robbins, TW. Impulsivity, compulsivity, and top-down cognitive control. Neuron. 2011; 69: 680694.
148. Ersche, KD, Sahakian, BJ. The neuropsychology of amphetamine and opiate dependence: implications for treatment. Neuropsychol Rev. 2007; 17: 317336.
149. Garavan, H, Stout, JC. Neurocognitive insights into substance abuse. Trends Cogn Sci. 2005; 9: 195201.
150. Goldstein, RZ, Volkow, ND. Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications. Nat Rev Neurosci. 2011; 12: 652669.
151. Jentsch, JD, Taylor, JR. Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli. Psychopharmacology (Berl). 1999; 146(4): 373390.
152. Rogers, RD, Robbins, TW. Investigating the neurocognitive deficits associated with chronic drug misuse. Curr Opin Neurobiol. 2001; 11: 250257.
153. Verdejo-García, A, Lawrence, AJ, Clark, L. Impulsivity as a vulnerability marker for substance use disorders: review of findings from high-risk research, problem gamblers and genetic association studies. Neurosci Biobehav Rev. 2008; 32: 777810.
154. Belin, D, Mar, AC, Dalley, JW, Robbins, TW, Everitt, BJ. High impulsivity predicts the switch to compulsive cocaine-taking. Science. 2008; 320: 13521355.
155. Dalley, JW, Fryer, TD, Brichard, L, etal. Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science. 2007; 315: 12671270.
156. Diergaarde, L, Pattij, T, Poortvliet, I, etal. Impulsive choice and impulsive action predict vulnerability to distinct stages of nicotine seeking in rats. Biol Psychiatry. 2008; 63: 301308.
157. Economidou, D, Pelloux, Y, Robbins, TW, Dalley, JW, Everitt, BJ. High impulsivity predicts relapse to cocaine-seeking after punishment-induced abstinence. Biol Psychiatry. 2009; 65: 851856.
158. Broos, N, Diergaarde, L, Schoffelmeer, ANM, Pattij, T, De Vries, TJ. Trait impulsive choice predicts resistance to extinction and propensity to relapse to cocaine seeking: a bidirectional investigation. Neuropsychopharmacology. 2012; 37: 13771386.
159. Perry, JL, Larson, EB, German, JP, Madden, GJ, Carroll, ME. Impulsivity (delay discounting) as a predictor of acquisition of IV cocaine self-administration in female rats. Psychopharmacology (Berl). 2005; 178(2–3): 193201.
160. Poulos, CX, Le, AD, Parker, JL. Impulsivity predicts individual susceptibility to high levels of alcohol self-administration. Behav Pharmacol. 1995; 6: 810814.
161. McNamara, R, Dalley, JW, Robbins, TW, Everitt, BJ, Belin, D. Trait-like impulsivity does not predict escalation of heroin self-administration in the rat. Psychopharmacology (Berl). 2010; 212(4): 453464.
162. Schippers, MC, Binnekade, R, Schoffelmeer, ANM, Pattij, T, De Vries, TJ. Unidirectional relationship between heroin self-administration and impulsive decision-making in rats. Psychopharmacology (Berl). 2012; 219(2): 443452.
163. Dalley, JW, Laane, K, Theobald, DE, etal. Enduring deficits in sustained visual attention during withdrawal of intravenous methylenedioxymethamphetamine self-administration in rats: results from a comparative study with d-amphetamine and methamphetamine. Neuropsychopharmacology. 2007; 32: 11951206.
164. Gipson, CD, Bardo, MT. Extended access to amphetamine self-administration increases impulsive choice in a delay discounting task in rats. Psychopharmacology (Berl). 2009; 207(3): 391400.
165. Mendez, IA, Simon, NW, Hart, N, etal. Self-administered cocaine causes long-lasting increases in impulsive choice in a delay discounting task. Behav Neurosci. 2010; 124: 470477.
166. Winstanley, CA, Bachtell, RK, Theobald, DEH, etal. Increased impulsivity during withdrawal from cocaine self-administration: role for ΔFosB in the orbitofrontal cortex. Cereb Cortex. 2009; 19: 435444.
167. Yoon, JH, Higgins, ST, Heil, SH, etal. Delay discounting predicts postpartum relapse to cigarette smoking among pregnant women. Exp Clin Psychopharmacol. 2007; 15: 176186.
168. Ersche, KD, Jones, PS, Williams, GB, etal. Abnormal brain structure implicated in stimulant drug addiction. Science. 2012; 335: 601604.
169. Ersche, KD, Turton, AJ, Chamberlain, SR, etal. Cognitive dysfunction and anxious-impulsive personality traits are endophenotypes for drug dependence. Am J Psychiatry. 2012; 169: 926936.
170. Ersche, KD, Turton, AJ, Pradhan, S, Bullmore, ET, Robbins, TW. Drug addiction endophenotypes: impulsive versus sensation-seeking personality traits. Biol Psychiatry. 2010; 68: 770773.
171. Ersche, KD, Jones, PS, Williams, GB, etal. Distinctive personality traits and neural correlates associated with stimulant drug use versus familial risk of stimulant dependence. Biol Psychiatry. 2013; 74(2): 137144.
172. Audrain-McGovern, J, Rodriguez, D, Epstein, LH, etal. Does delay discounting play an etiological role in smoking or is it a consequence of smoking? Drug Alcohol Depend. 2009; 103: 99106.
173. Nigg, JT, Wong, MM, Martel, MM, etal. Poor response inhibition as a predictor of problem drinking and illicit drug use in adolescents at risk for alcoholism and other substance use disorders. J Am Acad Child Adolesc Psychiatry. 2006; 45: 468475.
174. Goudriaan, AE, Grekin, ER, Sher, KJ. Decision making and response inhibition as predictors of heavy alcohol use: a prospective study. Alcohol Clin Exp Res. 2011; 35: 10501057.
175. Parsegian, A, Glen, WB Jr, Lavin, A, See, RE. Methamphetamine self-administration produces attentional set-shifting deficits and alters prefrontal cortical neurophysiology in rats. Biol Psychiatry. 2011; 69: 253259.
176. Calu, DJ, Stalnaker, TA, Franz, TM, etal. Withdrawal from cocaine self-administration produces long-lasting deficits in orbitofrontal-dependent reversal learning in rats. Learn Mem. 2007; 14: 325328.
177. Porter, JN, Olsen, AS, Gurnsey, K, etal. Chronic cocaine self-administration in rhesus monkeys: impact on associative learning, cognitive control, and working memory. J Neurosci. 2011; 31: 49264934.
178. Lesscher, HMB, Vanderschuren, LJMJ. Compulsive drug use and its neural substrates. Rev Neurosci. 2012; 23: 731745.
179. Vanderschuren, LJMJ, Ahmed, SH. Animals studies of addictive behavior. Cold Spring Harb Perspect Med. 2013; 3(4): a011932.
180. Deroche-Gamonet, V, Belin, D, Piazza, PV. Evidence for addiction-like behavior in the rat. Science. 2004; 305: 10141017.
181. Hopf, FW, Chang, SJ, Sparta, DR, Bowers, MS, Bonci, A. Motivation for alcohol becomes resistant to quinine adulteration after 3 to 4 months of intermittent alcohol self-administration. Alcohol Clin Exp Res. 2010; 34: 15651573.
182. Jonkman, S, Pelloux, Y, Everitt, BJ. Differential roles of the dorsolateral and midlateral striatum in punished cocaine seeking. J Neurosci. 2012; 32: 46454650.
183. Lesscher, HMB, Van Kerkhof, LWM, Vanderschuren, LJMJ. Inflexible and indifferent ethanol drinking in mice. Alcohol Clin Exp Res. 2010; 34: 12191225.
184. Pelloux, Y, Everitt, BJ, Dickinson, A. Compulsive drug seeking by rats under punishment: effects of drug taking history. Psychopharmacology (Berl). 2007; 194(1): 127137.
185. Vanderschuren, LJMJ, Everitt, BJ. Drug seeking becomes compulsive after prolonged cocaine self-administration. Science. 2004; 305: 10171019.
186. Wolffgramm, J. An ethopharmacological approach to the development of drug addiction. Neurosci Biobehav Rev. 1991; 15(4): 515519.
187. Bock, R, Shin, JH, Kaplan, AR, etal. Strengthening the accumbal indirect pathway promotes resilience to compulsive cocaine use. Nat Neurosci. 2013; 16: 632638.
188. Chen, BT, Yau, HJ, Hatch, C, etal. Rescuing cocaine-induced prefrontal cortex hypoactivity prevents compulsive cocaine seeking. Nature. 2013; 496: 359362.
189. Kasanetz, F, Deroche-Gamonet, V, Berson, N, etal. Transition to addiction is associated with a persistent impairment in synaptic plasticity. Science. 2010; 328: 17091712.
190. Kasanetz, F, Lafourcade, M, Deroche-Gamonet, V, etal. Prefrontal synaptic markers of cocaine addiction-like behavior in rats. Mol Psychiatry. 2013; 18(6): 729737.
191. Pelloux, Y, Dilleen, R, Economidou, D, Theobald, D, Everitt, BJ. Reduced forebrain serotonin transmission is causally involved in the development of compulsive cocaine seeking in rats. Neuropsychopharmacology. 2012; 37(11): 25052514.
192. Everitt, BJ, Robbins, TW. From the ventral to the dorsal striatum: devolving views of their roles in drug addiction. Neurosci Biobehav Rev. 2013; 37(9 Pt A): 19461954.
193. Robbins, TW, Gillan, CM, Smith, DG, de Wit, S, Ersche, KD. Neurocognitive endophenotypes of impulsivity and compulsivity: towards dimensional psychiatry. Trends Cogn Sci. 2012; 16: 8191.
194. Meunier, D, Ersche, KD, Craig, KJ, etal. Brain functional connectivity in stimulant drug dependence and obsessive-compulsive disorder. Neuroimage. 2012; 59: 14611468.
195. Potenza, MN. Neurobiology of gambling behaviors. Curr Opin Neurobiol. 2013; 23(4): 660667.
196. Potenza, MN. Biological contributions to addictions in adolescents and adults: prevention, treatment and policy implications. J Adolesc Health. 2013; 52: s22s32.
197. Balodis, IM, Kober, H, Worhunsky, PD, etal. Diminished fronto-striatal activity during processing of monetary rewards and losses in pathological gambling. Biol Psychiatry. 2012; 71: 749757.
198. Choi, J-S, Shin, Y-C, Jung, WH, etal. Altered brain activity during reward anticipation in pathological gambling and obsessive-compulsive disorder. PLoS One. 2012; 7(9): e45938.
199. Wrase, J, Schlagenhauf, F, Kienast, T, etal. Dysfunction of reward processing correlates with alcohol craving in detoxified alcoholics. Neuroimage. 2007; 35: 787794.
200. Beck, A, Schlagenhauf, F, Wustenberg, T, etal. Ventral striatal activation during reward anticipation correlates with impulsivity in alcoholics. Biol Psychiatry. 2009; 66: 734742.
201. Lawrence, AJ, Luty, J, Bogdan, NA, Sahakian, BJ, Clark, L. Problem gamblers share deficits in impulsive decision-making with alcohol dependent individuals. Addiction. 2009; 104: 10061015.
202. Gearhardt, AN, White, MA, Potenza, MN. Binge eating disorder and food addiction. Curr Drug Abuse Rev. 2011; 4(3): 201207.
203. Balodis, IM, Kober, H, Worhunsky, PD, etal. Monetary reward processing in obese individuals with and without binge eating disorder. Biol Psychiatry. 2013; 73(9): 877886.
204. Balodis, IM, Grilo, CM, Kober, H, Worhunsky, PD, White, MA, Stevens, MC, Pearlson, GD, Potenza, MN. A pilot study linking reduced fronto-striatal recruitment during reward processing to persistent bingeing following treatment for binge-eating disorder. Int J Eat Disord. In press. DOI: 10.1002/eat.22204.
205. Ziauddeen, H, Farooqi, IS, Fletcher, PC. Obesity and the brain: how convincing is the addiction model? Nat Rev Neurosci. 2012; 13: 279286.
206. Avena, NM, Gearhardt, AN, Gold, MS, Wang, GJ, Potenza, MN. Tossing the baby out with the bathwater after a brief rinse? The potential downside of dismissing food addiction based on limited data. Nat Rev Neurosci. 2012; 13: 514.
207. Ziauddeen, H, Farooqi, IS, Fletcher, PC. Food addiction: Is there a baby in the bathwater? Nat Rev Neurosci. 2012; 13: 514.
208. Zald, DH, Boileau, I, El-Dearedy, W, etal. Dopamine transmission in the human striatum during monetary reward tasks. J Neurosci. 2004; 24(17): 41054112.
209. Frascella, J, Potenza, MN, Brown, LL, Childress, AR. Shared brain vulnerabilities open the way for nonsubstance addictions: carving addiction at a new joint? Ann N Y Acad Sci. 2010; 1187: 294315.
210. Leeman, RF, Potenza, MN. A targetted review of the neurobiology and genetics of behavioural addictions; an emerging area of research. Can J Psychiatry. 2013; 58(5): 260273.
211. Evans, AH, Pavese, N, Lawrence, AD, etal. Compulsive drug use linked to sensitized ventral striatal dopamine transmission. Ann Neurol. 2006; 59(5): 852858.
212. Millan, MJ, Agid, Y, Brüne, M, etal. Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy. Nat Rev Drug Discov. 2012; 11(2): 141168.
213. Niv, S, Tuvblad, C, Raine, A, Wang, P, Baker, LA. Heritability and longitudinal stability of impulsivity in adolescence. Behav Genet. 2012; 42(3): 378392.
214. Coccaro, EF, Bergeman, CS, McClearn, GE. Heritability of irritable impulsiveness: a study of twins reared together and apart. Psychiatry Res. 1993; 48: 229249.
215. Kendler, KS, Aggen, SH, Czajkowski, N, etal. The structure of genetic and environmental risk factors for DSM-IV personality disorders. Arch Gen Psychiatry. 2008; 65(12): 14381446.
216. Hur, YM, Bouchard, TJ Jr. The genetic correlation between impulsivity and sensation seeking traits. Behav Genet. 1997; 27(5): 455463.
217. Pedersen, NL, Plomin, R, McClearn, GE, Friberg, L. Neuroticism, extraversion, and related traits in adult twins reared apart and reared together. J Pers Soc Psychol. 1988; 55(6): 950957.
218. Seroczynski, AD, Bergeman, CS, Coccaro, EF. Etiology of the impulsivity/aggression relationship: genes or environment? Psychiatry Res. 1999; 86(1): 4157.
219. Livesley, WJ, Jang, KL, Vernon, PA. Phenotypic and genetic structure of traits delineating personality disorder. Arch Gen Psychiatry. 1998; 55(10): 941948.
220. Stoltenberg, SF, Christ, CC, Highland, KB. Serotonin system gene polymorphisms are associated with impulsivity in a context dependent manner. Prog Neuropsychopharmacol Biol Psychiatry. 2012; 39(1): 182191.
221. Gorwood, P, Le Strat, Y, Ramoz, N, etal. Genetics of dopamine receptors and drug addiction. Hum Genet. 2012; 131(6): 803822.
222. White, MJ, Morris, CP, Lawford, BR, Young, RM. Behavioral phenotypes of impulsivity related to the ANKK1 gene are independent of an acute stressor. Behav Brain Funct. 2008; 4: 54.
223. Eisenberg, DT, Mackillop, J, Modi, M, etal. Examining impulsivity as an endophenotype using a behavioral approach: a DRD2 TaqI A and DRD4 48-bp VNTR association study. Behav Brain Funct. 2007; 3: 2.
224. Rodriguez-Jimenez, R, Ãvila, C, Ponce, G, etal. The TaqIA polymorphism linked to the DRD2 gene is related to lower attention and less inhibitory control in alcoholic patients. Eur Psychiatry. 2006; 21: 6669.
225. Gorwood, P, Le Strat, Y, Ramoz, N, etal. Genetics of dopamine receptors and drug addiction. Hum Genet. 2012; 131(6): 803822.
226. Robbins, T, Gillan, C, Smith, D, de Wit, S, Ersche, K. Neurocognitive endophenotypes of impulsivity and compulsivity: towards dimensional psychiatry. Trends Cogn Sci. 1996; 16(1): 8191.
227. Whelan, R, Conrod, PJ, Poline, JB, etal. IMAGEN Consortium. Adolescent impulsivity phenotypes characterized by distinct brain networks. Nat Neurosci. 2012; 15(6): 920925.
228. Brunner, HG, Nelen, M, Breakefield, XO, Ropers, HH, van Oost, BA. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science. 1993; 262: 578580.
229. Bevilacqua, L, Doly, S, Kaprio, J, etal. A population-specific HTR2B stop codon predisposes to severe impulsivity. Nature. 2010; 468(7327): 10611066.
230. Streeter, CC, Terhune, DB, Whitfield, TH, etal. Performance on the Stroop predicts treatment compliance in cocaine-dependent individuals. Neuropsychopharmacology. 2008; 33: 827836.
231. Marissen, MA, Franken, IH, Waters, AJ, etal. Attentional bias predicts heroin relapse following treatment. Addiction. 2006; 101: 13061312.
232. Cox, WM, Hogan, LM, Kristian, MR, Race, JH. Alcohol attentional bias as a predictor of alcohol abusers’ treatment outcome. Drug Alcohol Depend. 2002; 68: 237243.
233. Waters, AJ, Shiffman, S, Sayette, MA, etal. Attentional bias predicts outcome in smoking cessation. Health Psychol. 2003; 22: 378387.
234. Schmitz, JM, Mooney, ME, Green, CE, etal. Baseline neurocognitive profiles differentiate abstainers and non-abstainers in a cocaine clinical trial. J Addict Dis. 2009; 28: 250257.
235. Bowden-Jones, H, McPhillips, M, Rogers, R, Hutton, S, Joyce, E. Risk-taking on tests sensitive to ventromedial prefrontal cortex dysfunction predicts early relapse in alcohol dependency: a pilot study. J Neuropsychiatry Clin Neurosci. 2005; 17: 417420.
236. Passetti, F, Clark, L, Mehta, MA, Joyce, E, King, M. Neuropsychological predictors of clinical outcome in opiate addiction. Drug Alcohol Depend. 2008; 94: 8291.
237. Krishnan-Sarin, S, Reynolds, B, Duhig, AM, etal. Behavioral impulsivity predicts treatment outcome in a smoking cessation program for adolescent smokers. Drug Alcohol Depend. 2007; 88: 7982.
238. Goudriaan, AE, Oosterlaan, J, de Beurs, E, van den Brink, W. The role of self-reported impulsivity and reward sensitivity versus neurocognitive measures of disinhibition and decision-making in the prediction of relapse in pathological gamblers. Psychol Med. 2008; 38: 4150.
239. Alvarez-Moya, EM, Ochoa, C, Jimenez-Murcia, S, etal. Effect of executive functioning, decision-making and self-reported impulsivity on the treatment outcome of pathologic gambling. J Psychiatry Neurosci. 2011; 36: 165175.
240. Blanco, C, Potenza, MN, Kim, SW, etal. A pilot study of impulsivity and compulsivity in pathological gambling. Psychiatry Res. 2009; 167: 161168.
241. Grant, JE, Chamberlain, SR, Odlaug, BL, Potenza, MN, Kim, SW. Open-label memantine treatment of pathological gambling reduces gambling severity and cognitive inflexibility: a pilot study. Psychopharmacology (Berl). 2010; 212(4): 603612.
242. Passetti, F, Clark, L, Davis, P, etal. Risky decision-making predicts short-term outcome of community but not residential treatment for opiate addiction: implications for case management. Drug Alcohol Depend. 2011; 118: 1218.
243. Moritz, S, Kloss, M, Jacobsen, D, etal. Neurocognitive impairment does not predict treatment outcome in obsessive-compulsive disorder. Behav Res Ther. 2005; 43: 811819.
244. Flessner, CA, Allgair, A, Garcia, A, etal. The impact of neuropsychological functioning on treatment outcome in pediatric obsessive-compulsive disorder. Depress Anxiety. 2010; 27: 365371.
245. Hoexter, MQ, Dougherty, DD, Shavitt, RG, etal. Differential prefrontal gray matter correlates of treatment response to fluoxetine or cognitive-behavioral therapy in obsessive–compulsive disorder. Eur Neuropsychopharm. 2013; 23(7): 569580.
246. Paulus, MP, Tapert, SF, Schuckit, MA. Neural activation patterns of methamphetamine-dependent subjects during decision making predict relapse. Arch Gen Psychiatry. 2005; 62: 761768.
247. Worhunsky, PD, Stevens, MC, Carroll, KM, etal. Functional Brain Networks Associated with Cognitive Control, Cocaine Dependence and Treatment Outcome. Psychol Addict Behav. 2013; 27(2): 477488.
248. Potenza, MN, Balodis, IM, Franco, CA, etal. Neurobiological considerations in understanding behavioral treatments for pathological gambling. Psychol Addict Behav. 2013; 27(2): 380392.
249. Krishnan-Sarin, S, Balodis, IM, Kober, H, etal. A preliminary examination of the relationship between neural correlates of cognitive control and reduction in cigarette use among treatment-seeking adolescent smokers. Psychol Addict Behav. 2013; 27(2): 526532.
250. Janes, AC, Pizzagalli, DA, Richardt, S, etal. Brain reactivity to smoking cues prior to smoking cessation predicts ability to maintain tobacco abstinence. Biol Psychiatry. 2010; 67(8): 722729.
251. Cousijn, J, Wiers, RW, Ridderinkhof, KR, etal. Individual differences in decision making and reward processing predict changes in cannabis use: a prospective functional magnetic resonance imaging study. Addict Biol. 2013; 18(6): 10131023.
252. O'Neill, J, Gorbis, E, Feusner, JD, etal. Effects of intensive cognitive-behavioral therapy on cingulate neurochemistry in obsessive-compulsive disorder. J Psychiatr Res. 2013; 47(4): 494504.
253. Hoexter, MQ, de Souza Duran, FL, D'Alcante, CC, etal. Gray matter volumes in obsessive-compulsive disorder before and after fluoxetine or cognitive-behavior therapy: a randomized clinical trial. Neuropsychopharmacology. 2012; 37(3): 734745.
254. Huyser, C, Veltman, DJ, Wolters, LH, de Haan, E, Boer, F. Developmental aspects of error and high-conflict-related brain activity in pediatric obsessive-compulsive disorder: a fMRI study with a Flanker task before and after CBT. J Child Psychol Psychiatry. 2011; 52(12): 12511260.
255. Freyer, T, Klöppel, S, Tüscher, O, etal. Frontostriatal activation in patients with obsessive-compulsive disorder before and after cognitive behavioral therapy. Psychol Med. 2011; 41(1): 207216.
256. Apostolova, I, Block, S, Buchert, R, etal. Effects of behavioral therapy or pharmacotherapy on brain glucose metabolism in subjects with obsessive-compulsive disorder as assessed by brain FDG PET. Psychiatry Res. 2010; 184(2): 105116.
257. Saxena, S, Gorbis, E, O'Neill, J, etal. Rapid effects of brief intensive cognitive-behavioral therapy on brain glucose metabolism in obsessive-compulsive disorder. Mol Psychiatry. 2009; 14(2): 197205.
258. Morgenstern, J, Naqvi, NH, Debellis, R, Breiter, HC. The contributions of cognitive neuroscience and neuroimaging to understanding mechanisms of behavior change in addiction. Psychol Addict Behav. 2013; 27(2): 336350.
259. Vollstädt-Klein, S, Loeber, S, Richter, A, etal. Validating incentive salience with functional magnetic resonance imaging: association between mesolimbic cue reactivity and attentional bias in alcohol-dependent patients. Addict Biol. 2011; 17(4): 807816.
260. DeVito, E, Worhunsky, P, Carroll, K, etal. A preliminary study of the neural effects of behavioral therapy for substance use disorders. Drug Alcohol Depend. 2012; 122(3): 228235.
261. Martinez, D, Carpenter, KM, Liu, F, etal. Imaging dopamine transmission in cocaine dependence: link between neurochemistry and response to treatment. Am J Psychiatry. 2011; 168(6): 634641. Erratum in: Am J Psychiatry. 2011; 168(5): 553.
262. Del Campo, N, Chamberlain, SR, Sahakian, BJ, Robbins, TW. The roles of dopamine and noradrenaline in the pathophysiology and treatment of attention-deficit/hyperactivity disorder. Biol Psychiatry. 2011; 69(12): e145e157.
263. Mehta, MA, Sahakian, BJ, McKenna, PJ, Robbins, TW. Systemic sulpiride in young adult volunteers simulates the profile of cognitive deficits in Parkinson's disease. Psychopharmacology (Berl). 1999; 146(2): 162174.
264. Harmer, CJ. Serotonin and emotional processing: does it help explain antidepressant drug action? Neuropharmacology 2008; 55(6): 10231028.